January 27, 2026
From left: Katelyn Jetalina, Jessica Malaty Rivera, Jay Shetty, Darien Sutton.
Illustration: Camille MacMillin/STAT; Photos: Courtesy

9 influencers shaping health information online, for better or worse

A look at three categories of wellness influencers — experts, entertainers, and MAHA mobilizers — and how their health content is shaping public opinion.

By Alexa Lee


STAT+ | Newborn screening can save lives, but worries about potential harm slow adoption in the U.K.

U.K. government pressured to expand the list of screened diseases from 10 to closer to the dozens used in other countries. Advocates say lives are at stake.

By Andrew Joseph


STAT+ | UnitedHealth limps into 2026 with a smaller business and fresh challenges

UnitedHealth execs are aiming to cut unprofitable businesses to boost profits, but changes to Medicare policies are a new hurdle.

By Bob Herman and Tara Bannow



People pay their respects at a memorial site for Alex Pretti in Minneapolis, Minn.
Brandon Bell/Getty Images

Opinion: Alex Pretti was a nurse to the end

Alex Pretti’s final moments in Minneapolis reflect the instinctive application of nursing’s ethical principles.

By Patrick Smith


STAT+ | HCA expects $1 billion hit from loss of ACA tax credits, Medicaid changes

HCA Healthcare is facing down changes to the Affordable Care Act and Medicaid that could cut into profits.

By Tara Bannow


STAT+ | Roche moves obesity drug to pivotal trials after mid-stage success

The company plans to start the Phase 3 studies this quarter after the drug, CT-388, led to substantial weight loss in a Phase 2 trial.

By Andrew Joseph


JEFF PACHOUD/AFP via Getty Images

Opinion: I was an undocumented immigrant. Now I’m a doctor watching the immigration crackdown keep my patients from seeking care

When immigration enforcement enters exam rooms, labor units, and postpartum clinics, the health system itself becomes collateral damage.

By Jesus Ruiz


Opinion: Sidelining Black women in clinical trials is not just a moral failure. It’s bad science

Evidence for universally adopted cancer treatment guidelines is incomplete when trial participants aren't representative.

By Yehoda Martei


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2026, All Rights Reserved.